Answers are grounded in this paper and cite their sources.
Retrospective study explores infection rates in CAR T-cell patients using tocilizumab, suggesting no increased risk.
Purpose Chimeric antigen receptor (CAR) T-cell therapy has reshaped the outlook for patients with relapsed or refractory hematologic malignancies. In pivotal trials, infections occurred in 19–56% and 42–69% of patients receiving CD19- and B-cell maturation antigen (BCMA)-directed therapies, respectively. Administration of corticosteroids and tocilizumab may further increase the risk of infection. The study purpose is to determine if tocilizumab administration leads to a higher incidence of infection after receiving CAR T-cell therapy. Methods This is a single-center retrospective study analyzing 198 patients who received CAR T-cell treatment from June 1, 2018 through August 21, 2023. Patients who received tocilizumab after CAR T-cell administration were compared to patients who did not. The primary outcome is the incidence of documented infection within 90 days of receiving CAR T-cell therapy. Results During their index admission, 100 patients received tocilizumab after CAR T-cell therapy and 98 patients did not receive tocilizumab. Within 90 days of CAR T-cell administration, the incidence of any infection was 31.6% in patients who did not receive tocilizumab compared to 33% in patients who received tocilizumab (p = 0.837). Positive bacterial cultures occurred in 9.2% of patients who did not receive tocilizumab compared to 20% of patients who did receive tocilizumab (p = 0.031); however, this was not supported with logistic regression (p = 0.076). Conclusion In conclusion, tocilizumab administration did not appear to increase the risk of infection within 90 days after CAR T-cell therapy. These results are limited by the retrospective, single-center nature of the study. A multicenter cohort is recommended to further validate these results.
No takes yet. Share an insight, caveat, or question.
Bland et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: